Bond.az White LogoBond.az Black Logo

Morgan Stanley Backs AppLovin on Conversion Growth

Morgan Stanley reiterates Overweight on AppLovin with $720 target, highlighting conversion growth potential and strong Q1 results.

Sophia Anderson
BySophia Anderson- Senior Editor
|
0

Morgan Stanley reiterated an Overweight rating on AppLovin Corp (NASDAQ:APP) with a $720.00 price target. The company, valued at $172.75 billion, has shown exceptional growth with revenue surging 66% over the last twelve months to $6.16 billion.

The firm said AppLovin can sustain above-market growth by expanding its conversion rate, as approximately 99% of its ads still do not generate a conversion. A 10x conversion rate gap exists between AppLovin and market leaders, implying significant headroom.

Improvements would stem from scale and data advantages, continued mix shift into non-endemic ads, and lower repeat rates. AppLovin's conversion rate has expanded 30 basis points over the last 18 months. Each additional 10 basis points would drive 17 points of net revenue growth.

If AppLovin maintains 20 basis points of annual conversion rate expansion, it could see revenue and EBITDA approximately 50% above consensus by 2030, putting Morgan Stanley's $1,100 bull case in play. The company's impressive 88% gross profit margin supports its ability to invest in conversion optimization.

In recent news, AppLovin reported strong Q1 2026 results, beating earnings and revenue forecasts. EPS of $3.56 exceeded the expected $3.42, while revenue of $1.84 billion topped the forecast of $1.78 billion. Several analysts raised price targets, including Piper Sandler ($665), Wolfe Research ($580), Goldman Sachs ($585), and Jefferies ($700).

More News
Today / 12:31
|
689

Hershey Stock Upgraded on Confection Outlook

Evercore ISI upgrades Hershey to Outperform with a $255 price target, citing positive confection outlook and attractive valuation.

0
Today / 12:31
|
281

Argus Downgrades Zoetis Stock Rating

Argus downgrades Zoetis stock to Hold on competition and margin pressure. Analyst outlook and Zoetis performance insights.

0
Today / 11:04
|
827

Evercore ISI Reiterates Amphenol Outperform $180 Target

Evercore ISI reiterates Outperform rating and $180 target on Amphenol. AI revenue could exceed $9 billion by 2026.

0
Today / 11:03
|
415

Okta price target raised to $110 by Cantor

Cantor Fitzgerald raised Okta price target to $110 from $100, citing workforce growth. Stock has 17% upside. Earnings due May 28.

0
Today / 11:02
|
602

Oppenheimer Cuts Deere Price Target on Brazil Weakness

Oppenheimer cut Deere's price target to $680 from $715, citing Brazil agricultural weakness and tariff impacts, while maintaining an Outperform rating.

0
Today / 09:33
|
700

Truist Cuts Zscaler Price Target to $200

Truist Securities cuts Zscaler price target to $200, maintains Buy rating. Conservative FY2027 outlook drives stock down 20%.

0
Today / 09:32
|
715

Guggenheim Reiterates Neutral on CrowdStrike Stock

Guggenheim maintains Neutral rating on CrowdStrike (CRWD) citing valuation. Read analysis on stock performance and outlook.

0
Today / 09:01
|
256

Mizuho Starts Century Therapeutics at Outperform

Mizuho initiated coverage on Century Therapeutics with an Outperform rating and $8.00 target, highlighting cell therapy for Type 1 Diabetes.

0
Today / 07:32
|
969

Barclays Upgrades GXO, Raises Price Target to $65

Barclays upgrades GXO Logistics to Overweight, raising price target to $65, citing margin improvement and US expansion.

0
Today / 06:35
|
238

JPMorgan Initiates Larimar at Overweight

JPMorgan starts Larimar Therapeutics at Overweight with $9 target. Stock at $3.47. Key developments on nomlabofusp.

0
Today / 06:02
|
267

Seaport Starts GE Aerospace Coverage with Buy

Seaport Global Securities starts GE Aerospace coverage with a buy rating and $375 price target, citing aftermarket growth potential.

0
Yesterday / 19:30
|
683

Truist Cuts Boston Properties Price Target on Rates

Truist Securities cuts Boston Properties target to $64 from $70, hold rating maintained. Higher rates and capex drive estimate reductions.

0
...